Glioblastoma Multiforme (GBM) Ongoing Global Clinical Trials Analysis and Outlook

June 2018 | 389 pages | ID: G8C4A7F8F01EN
VPAResearch

Abstracts

Glioblastoma Multiforme (GBM) ongoing clinical trials report from VPA Research provides comprehensive analysis and trends in global Glioblastoma Multiforme (GBM) disease clinical trials. The research work analyzes the ongoing Glioblastoma Multiforme (GBM) clinical trial trends across countries and companies.

The report focuses on drugs and therapies being evaluated for Glioblastoma Multiforme (GBM) treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, enrollment, phases, trial status and sponsor types.

Our experienced database team dynamically updates the clinical trials data from several sources including Clinical trial registries, conferences, journals and company releases etc. Further, data is presented in user friendly manner to enable readers quick access to Glioblastoma Multiforme (GBM) clinical trials.

Scope of the Report-

• Ongoing Glioblastoma Multiforme (GBM) clinical trials across regions
• Trial information by Phase and Subjects recruited
• Trial information by status, type, sponsor type
• Drugs used for treatment of Glioblastoma Multiforme (GBM)
• Both observational and interventional trials analyzed
• Leading companies and universities participating in Glioblastoma Multiforme (GBM) clinical trials

Reasons to Buy

• Track competition and design competitive advantages
• Identify right partners to associate with for further research
• Evaluate potential opportunities available in further clinical trials of the disease
• Formulate business development strategies through success rates of clinical trials
• Identify quick markets for recruiting subjects based on trials count by each market

Contents

1 TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2 KEY FINDINGS, 2018

2.1 Snapshot
2.2 Overview of Glioblastoma Multiforme (GBM) Trials

3 CLINICAL TRIALS TRENDS TO 2022

3.1 Ongoing Glioblastoma Multiforme (GBM) Trials by Phase
3.2 Ongoing Glioblastoma Multiforme (GBM) Trials by Type
3.3 Ongoing Glioblastoma Multiforme (GBM) Trials by Recruitment Status

4 COUNTRY LEVEL ANALYSIS

4.1 Region wise Ongoing Glioblastoma Multiforme (GBM) Trials
4.2 Top 10 Countries conducting Glioblastoma Multiforme (GBM) Trials
4.3 Trials in Emerging and Developing Economies

5 COMPANY LEVEL ANALYSIS

5.1 Ongoing Glioblastoma Multiforme (GBM) Trials by Sponsor Type
5.2 Glioblastoma Multiforme (GBM) Subjects by Sponsor Type
5.3 Subjects Recruited by Leading Sponsors

6 ENROLMENT TRENDS TO 2022

6.1 Subjects Recruited for Glioblastoma Multiforme (GBM) Trials by year
6.2 Subjects Recruited for Glioblastoma Multiforme (GBM) Trials by Phase
6.3 Subjects Recruited for Glioblastoma Multiforme (GBM) Trials by Trial Type
6.4 Subjects Recruited for Glioblastoma Multiforme (GBM) Trials by Recruitment Status

7 ONGOING TRIALS- PHASE, ID, TITLE, LOCATION, TYPE, DURATION, RECRUITMENT STATUS, COMPANY DETAILS

7.1 Ongoing Glioblastoma Multiforme (GBM) Trials- Phase
7.2 Ongoing Glioblastoma Multiforme (GBM) Trials- Phase
7.3 Ongoing Glioblastoma Multiforme (GBM) Trials- Phase
7.4 Ongoing Glioblastoma Multiforme (GBM) Trials- Phase

8 APPENDIX

8.1 Abbreviations and Definitions
8.2 Sources and Research Methodology

List Of Figures

LIST OF FIGURES

Figure 1: Glioblastoma Multiforme (GBM)- Clinical Trials by Country
Figure 2: Glioblastoma Multiforme (GBM)- Clinical Trials by Phase of Development, 2018
Figure 3: Glioblastoma Multiforme (GBM)- Clinical Trials by Status, 2018
Figure 4: Glioblastoma Multiforme (GBM)- Clinical Trials by Type, 2018
Figure 5: Glioblastoma Multiforme (GBM)- Clinical Trials Split by Region, 2000-2018
Figure 6: Glioblastoma Multiforme (GBM)- Clinical Trials by Type of Economy, 2018
Figure 7: Glioblastoma Multiforme (GBM)- Enrolment by Phase, 2018
Figure 8: Glioblastoma Multiforme (GBM)- Enrolment by Trial Type, 2018
Figure 9: Glioblastoma Multiforme (GBM)- Enrolment by Recruitment Status, 2018
Figure 10: Glioblastoma Multiforme (GBM)- Clinical Trials by Sponsor Type, 2018
Figure 11: Glioblastoma Multiforme (GBM)- Enrolment by Type of Sponsors
Figure 12: Glioblastoma Multiforme (GBM)- Enrolment by Leading Sponsors

List Of Tables

LIST OF TABLES

Table 1: Glioblastoma Multiforme (GBM)- Clinical Trials by Sponsor Type, 2018
Table 2: Glioblastoma Multiforme (GBM)- Clinical Trials by Economy Type, 2018
Table 3: Glioblastoma Multiforme (GBM)- Clinical Trials by Region, 2018
Table 4: Glioblastoma Multiforme (GBM)- Clinical Trial Participations of Top 10 Countries, 2018
Table 5: Glioblastoma Multiforme (GBM)- Clinical Trials in Emerging and Developing Economies, 2018
Table 6: Glioblastoma Multiforme (GBM)- Ongoing Phase 1 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 7: Glioblastoma Multiforme (GBM)- Ongoing Phase 2 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 8: Glioblastoma Multiforme (GBM)- Ongoing Phase 3 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company
Table 9: Glioblastoma Multiforme (GBM)- Ongoing Phase 4 Trial Details- Phase, ID, Title, Location, Type, Duration, Recruitment Status, Company